We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+783.94%
AUM
$429M
AUM Growth
+$8.73M
Cap. Flow
-$4.07M
Cap. Flow %
-0.95%
Top 10 Hldgs %
33.96%
Holding
360
New
39
Increased
44
Reduced
62
Closed
23

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.28M
2
TER icon
Teradyne
TER
+$2.82M
3
FCX icon
Freeport-McMoran
FCX
+$2.73M
4
MU icon
Micron Technology
MU
+$1.94M
5
PH icon
Parker-Hannifin
PH
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 20.35%
2 Healthcare 17.84%
3 Industrials 12.94%
4 Financials 12.24%
5 Energy 12.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSV icon
276
Vanguard Short-Term Bond ETF
BSV
$44.6B
$4.69K ﹤0.01%
62
DEO icon
277
Diageo
DEO
$49.2B
$4.34K ﹤0.01%
25
MET icon
278
MetLife
MET
$61.9B
$4.24K ﹤0.01%
75
FPI
279
Farmland Partners
FPI
$431M
$4.15K ﹤0.01%
340
UBER icon
280
Uber
UBER
$139B
$3.97K ﹤0.01%
92
LAND
281
Gladstone Land Corp
LAND
$354M
$3.9K ﹤0.01%
240
WSO icon
282
Watsco Inc
WSO
$13.7B
$3.81K ﹤0.01%
10
VZ icon
283
Verizon
VZ
$193B
$3.72K ﹤0.01%
100
OKTA icon
284
Okta
OKTA
$25.6B
$3.47K ﹤0.01%
50
BOTZ icon
285
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.48B
$3.36K ﹤0.01%
+117
New +$3.1K
T icon
286
AT&T
T
$158B
$2.86K ﹤0.01%
179
-50
-22% -$852
CRSP icon
287
CRISPR Therapeutics
CRSP
$5.07B
$2.81K ﹤0.01%
50
-2,000
-98% -$113K
FUND
288
Sprott Focus Trust
FUND
$301M
$2.78K ﹤0.01%
350
HPQ icon
289
HP
HPQ
$26.1B
$2.7K ﹤0.01%
88
+1
+1% +$30
MMM icon
290
3M
MMM
$93.9B
$2.5K ﹤0.01%
30
-121
-80% -$10.3K
TTEK icon
291
Tetra Tech
TTEK
$8.78B
$2.46K ﹤0.01%
75
DNMR
292
DELISTED
Danimer Scientific, Inc.
DNMR
$2.38K ﹤0.01%
25
UL icon
293
Unilever
UL
$139B
$2.19K ﹤0.01%
37
ZIM icon
294
ZIM Integrated Shipping Services
ZIM
$3.2B
$1.86K ﹤0.01%
150
NTRS icon
295
Northern Trust
NTRS
$33.7B
$1.85K ﹤0.01%
25
CTXR icon
296
Citius Pharmaceuticals
CTXR
$21.4M
$1.8K ﹤0.01%
+60
New +$1.98K
JWN
297
DELISTED
Nordstrom
JWN
$1.6K ﹤0.01%
78
ZG icon
298
Zillow
ZG
$8.44B
$1.57K ﹤0.01%
32
HPE icon
299
Hewlett Packard
HPE
$70.5B
$1.48K ﹤0.01%
88
GDYN icon
300
Grid Dynamics Holdings
GDYN
$600M
$1.39K ﹤0.01%
+150
New +$1.5K

Similar funds

Bourgeon Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bourgeon Capital Management held 360 positions worth $429M, up 2.1% from $420M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bourgeon Capital Management's Q2 2023 filing shows 39 new, 44 increased, 62 reduced and 23 closed positions. Its largest new stake was Teva Pharmaceuticals: 651,760 shares worth $4.91M. The largest sale was Jacobs Solutions, an estimated $7.04M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bourgeon Capital Management's largest Q2 2023 buy was Teva Pharmaceuticals: 651,760 shares worth $4.91M.
  • Bourgeon Capital Management added most to Teradyne in Q2 2023, an estimated $2.82M increase.
  • Bourgeon Capital Management's biggest Q2 2023 reduction was Jacobs Solutions, cutting an estimated $7.04M.
  • Bourgeon Capital Management fully exited Goldman Sachs MLP Energy Renaissance Fund in Q2 2023, selling an estimated $2.61M.
  • Bourgeon Capital Management's ten largest holdings make up 34% of its $429M portfolio in Q2 2023.
  • Bourgeon Capital Management opened 39 new positions and closed 23 in Q2 2023.
  • Bourgeon Capital Management's portfolio value rose 2.1% quarter-over-quarter to $429M.

Based on Bourgeon Capital Management's 13F filing for Q2 2023, filed 20 Jul 2023.